Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (2) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter

Decision date

From:

To:

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Procedure started Remove Procedure started filter

Referral type

Article 20 procedures (2) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (2) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures Remove Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter Exceptional circumstances (1) Apply Exceptional circumstances filter Generic (1) Apply Generic filter Orphan medicine (1) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter

Medicine type Accelerated assessment Remove Accelerated assessment filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Referral status European Commission final decision Remove European Commission final decision filter Procedure started Remove Procedure started filter

Referral PRAC recommendation Risk minimisation measures Remove Risk minimisation measures filter

Sort by

List item

Referral: Zynteglo

betibeglogene autotemcel, associated names: Zynteglo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/07/2021, EC decision date: 16/09/2021, Last updated: 11/10/2021
List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017

2 results

Referral: Zynteglo

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)